Epidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: A systematic review.
The general aim of this systematic review is to mitigate breast cancer (BC) overdiagnosis and overtreatment. The prevalence of invasive BC undiagnosed during lifetime range was 0-1.5%, while for DCIS the range was 0.2-14.7%. Spontaneous regression: 2 cohort studies, 3 case reports, 1 case series included. In the cohort studies the relative risk of regression for screen detected compared with nonscreened BC was estimated as 1.2 and 1.1. It seems plausible that around 10% of invasive BC are not symptomatic during life, and that one fifth of BC patients if untreated would be alive after 5 years. Around 1 of 10 screen-detected...
Source: Current Awareness Service for Health (CASH) - July 27, 2016 Category: Consumer Health News Source Type: news
Are provider-related factors affecting the likelihood of breast preservation?
( < i > The JAMA Network Journals < /i > ) Do regional practice patterns for radiotherapy for ductal carcinoma in situ (DCIS) breast cancer increase the likelihood of mastectomy when there is a second breast cancer in women who did not receive radiotherapy at the initial DCIS diagnosis? (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 21, 2016 Category: Cancer & Oncology Source Type: news
Medical News Today: Aggressive breast cancer identified with new technique
A combination of math and imaging can distinguish aggressive forms of ductal carcinoma in situ - or stage 0 breast cancer - from non-aggressive forms. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 3, 2016 Category: Consumer Health News Tags: Breast Cancer Source Type: news
New technology helps ID aggressive early breast cancer
Researchers have developed a new technology that can identify aggressive forms of ductal carcinoma in situ, or stage 0 breast cancer, from non-aggressive varieties. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 30, 2016 Category: Science Source Type: news
New technology helps ID aggressive early breast cancer
(University of Michigan Health System) Researchers at the University of Michigan developed a new technology that can identify aggressive forms of ductal carcinoma in situ, or stage 0 breast cancer, from non-aggressive varieties. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 30, 2016 Category: Global & Universal Source Type: news
